Ignite Creation Date:
2024-05-06 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05178511
Status:
RECRUITING
Last Update Posted:
2022-01-05
First Post:
2021-12-02
Brief Title:
Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance
Sponsor:
Li Zhang MD
Organization:
Sun Yat-sen University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| The Diagnosis Was ALK Positive NSCLC |
| Second Generation ALK-TKI is Resistant |
| Efficacy of Ensatinib in This Subset of Patients |
Keywords:
| Name | View |
|---|---|
| ensartinib | View |